Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance.
Gregg JR, Newcomb L, Wu R, Dennison J, Davis JW, Pettaway C, Pisters L, Ward JF, Chapin BF, Chéry L, Urkmez A, Fang AM, Higgason N, Troncoso P, Daniel CR, Logothetis C, Thompson TC, Hahn AW, Liu M, Zheng Y, Lin DW, Hanash S, Irajizad E, Fahrmann J. Gregg JR, et al. Among authors: ward jf. Biomark Res. 2024 Nov 9;12(1):134. doi: 10.1186/s40364-024-00678-7. Biomark Res. 2024. PMID: 39522029 Free PMC article.
The association of body mass index with tumor aggression among men undergoing radical prostatectomy.
Gregg JR, Magill R, Fang AM, Chapin BF, Davis JW, Adibi M, Chéry L, Papadopoulos J, Pettaway C, Pisters L, Ward JF, Hahn AW, Daniel CR, Bhaskaran J, Zhu K, Guerrero M, Zhang M, Troncoso P. Gregg JR, et al. Among authors: ward jf. Urol Oncol. 2024 Apr;42(4):116.e1-116.e7. doi: 10.1016/j.urolonc.2023.12.013. Epub 2024 Jan 22. Urol Oncol. 2024. PMID: 38262868
Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus.
Tan WP, Rastinehad AR, Klotz L, Carroll PR, Emberton M, Feller JF, George AK, Gill IS, Gupta RT, Katz AE, Lebastchi AH, Marks LS, Marra G, Pinto PA, Song DY, Sidana A, Ward JF, Sanchez-Salas R, Rosette J, Polascik TJ; Focal Therapy Group Authors. Tan WP, et al. Among authors: ward jf. Urol Oncol. 2021 Nov;39(11):781.e17-781.e24. doi: 10.1016/j.urolonc.2021.01.027. Epub 2021 Mar 4. Urol Oncol. 2021. PMID: 33676851 Free PMC article.
Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project.
van Luijtelaar A, Greenwood BM, Ahmed HU, Barqawi AB, Barret E, Bomers JGR, Brausi MA, Choyke PL, Cooperberg MR, Eggener S, Feller JF, Frauscher F, George AK, Hindley RG, Jenniskens SFM, Klotz L, Kovacs G, Lindner U, Loeb S, Margolis DJ, Marks LS, May S, Mcclure TD, Montironi R, Nour SG, Oto A, Polascik TJ, Rastinehad AR, De Reyke TM, Reijnen JS, de la Rosette JJMCH, Sedelaar JPM, Sperling DS, Walser EM, Ward JF, Villers A, Ghai S, Fütterer JJ. van Luijtelaar A, et al. Among authors: ward jf. World J Urol. 2019 Oct;37(10):2147-2153. doi: 10.1007/s00345-019-02636-7. Epub 2019 Jan 22. World J Urol. 2019. PMID: 30671638 Free PMC article.
Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative study.
Ghoreifi A, Mitra AP, McClintock G, Baky F, McDowell Z, Lavallée E, Saoud R, Cai J, Gill IS, Sfakianos J, Porter J, Bagrodia A, Ahmadi N, Eggener S, Ward JF, Djaladat H. Ghoreifi A, et al. Among authors: ward jf. Urol Oncol. 2023 Feb;41(2):111.e7-111.e14. doi: 10.1016/j.urolonc.2022.11.006. Epub 2022 Nov 24. Urol Oncol. 2023. PMID: 36437156
263 results